General Information of Drug (ID: DMZTPX3)

Drug Name
CIN-109
Indication
Disease Entry ICD 11 Status REF
Obesity 5B81 Phase 1 [1]
Cross-matching ID
TTD ID
D2OEG6

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Growth/differentiation factor 15 (GDF15) TT4MXVG GDF15_HUMAN Replacement [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of CinFina Pharma
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight